After documented suffering by Japanese athletes and insufficient mechanisms to report abuse, the government’s efforts to end mistreatment in sports are a positive step. However, effective ...
GSK plc has received Orphan Drug Designation in Japan for its investigational antibody-drug conjugate risvutatug rezetecan (Ris-Rez) for the treatment of small-cell lung cancer, supported by early ...